Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2010 - 2025)
Whitehawk Therapeutics (WHWK) reported Other Working Capital Changes of $817000.0 for Q3 2025, up 556.42% year-over-year from $124462.1 in Q3 2024, and up 200.0% quarter-over-quarter from -$817000.0 in Q2 2025.
Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 15 years of Other Working Capital Changes data on file, last reported at $817000.0 in Q3 2025.
- Other Working Capital Changes for Q3 2025 came in at $817000.0, up 556.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$89000.0 (up 82.62% YoY), and the FY2025 annual result was $518706.0, up 201.31% from the prior year.
- Other Working Capital Changes improved to $817000.0 in Q3 2025 per WHWK's latest filing, from -$817000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.1 million in Q4 2024 and troughed at -$1.9 million in Q4 2022.
- A 5-year average of -$80157.9 and a median of -$55000.0 in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 57800.0% in 2022 and fell as far as 23262.5% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$8000.0 in 2021, then plunged by 23262.5% to -$1.9 million in 2022, then jumped by 73.14% to -$502000.0 in 2023, then soared by 517.13% to $2.1 million in 2024, then sank by 60.98% to $817000.0 in 2025.
- Business Quant data shows WHWK's Other Working Capital Changes at $817000.0 in Q3 2025, -$817000.0 in Q2 2025, and -$89000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 817,000.00 |
| Sep 30, 2025 | 817,000.00 |
| Jun 30, 2025 | -817,000.00 |
| Jun 30, 2025 | -817,000.00 |
| Mar 31, 2025 | -89,000.00 |
| Mar 31, 2025 | -89,000.00 |
| Dec 31, 2024 | 2.09 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | -179,000.00 |
| Sep 30, 2024 | -179,000.00 |
| Jun 30, 2024 | -1.47 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -953,000.00 |
| Mar 31, 2024 | -953,000.00 |
| Dec 31, 2023 | -502,000.00 |
| Dec 31, 2023 | -502,000.00 |
| Sep 30, 2023 | 845,000.00 |
| Sep 30, 2023 | 845,000.00 |
| Jun 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -1.49 Mn |